HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?
- PMID:11873003
- DOI: 10.1097/00002030-200203080-00011
HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?
Abstract
Objectives: To describe the progression times of HIV-1 infection from seroconversion to AIDS and to death, and time from first developing AIDS to death in rural Uganda. Also, to describe the proportion of individuals within the cohort dying with AIDS and the CD4 lymphocyte count before death.
Design: A prospective, longitudinal, population-based cohort.
Methods: Since 1990, 107 HIV-prevalent cases, 168 incident cases and 235 HIV-seronegative controls have been recruited into a cohort in rural Uganda. Participants are recruited from the general population and they are reviewed routinely every 3 months and at other times when ill.
Results: The median time from seroconversion to death was 9.8 years. Age over 40 years at seroconversion was associated with more rapid progression (P < 0.001, log rank test). For the first 4 years of the study, HIV contributed little to the death rates in the HIV incident cases, but after 5 years, the contribution of HIV became greater and was particularly marked in the oldest age group. Survival rates in the cohort were similar to those in the general population. The median time from seroconversion to AIDS was 9.4 years and from AIDS to death was 9.2 months. Of those infected with HIV-1, 80% died with AIDS and 20% had a CD4 count < 10 x 106 cells/l.
Conclusions: Survival with HIV-1 infection is similar in Africa to industrialized countries before the use of antiretroviral therapy; when they do die, many of those in Africa are severely immunosuppressed and most have clinical features of AIDS.
Similar articles
- HIV-1 disease progression and AIDS-defining disorders in rural Uganda.Morgan D, Maude GH, Malamba SS, Okongo MJ, Wagner HU, Mulder DW, Whitworth JA.Morgan D, et al.Lancet. 1997 Jul 26;350(9073):245-50. doi: 10.1016/S0140-6736(97)01474-8.Lancet. 1997.PMID:9242801
- Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort.Kaleebu P, Ross A, Morgan D, Yirrell D, Oram J, Rutebemberwa A, Lyagoba F, Hamilton L, Biryahwaho B, Whitworth J.Kaleebu P, et al.AIDS. 2001 Feb 16;15(3):293-9. doi: 10.1097/00002030-200102160-00001.AIDS. 2001.PMID:11273208
- An HIV-1 natural history cohort and survival times in rural Uganda.Morgan D, Malamba SS, Maude GH, Okongo MJ, Wagner HU, Mulder DW, Whitworth JA.Morgan D, et al.AIDS. 1997 Apr;11(5):633-40. doi: 10.1097/00002030-199705000-00011.AIDS. 1997.PMID:9108945
- The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review.Jaffar S, Grant AD, Whitworth J, Smith PG, Whittle H.Jaffar S, et al.Bull World Health Organ. 2004 Jun;82(6):462-9.Bull World Health Organ. 2004.PMID:15356940Free PMC article.Review.
- Mortality impact of the AIDS epidemic: evidence from community studies in less developed countries.Boerma JT, Nunn AJ, Whitworth JA.Boerma JT, et al.AIDS. 1998;12 Suppl 1:S3-14.AIDS. 1998.PMID:9677185Review.
Cited by
- Mathematical insights in evaluating state dependent effectiveness of HIV prevention interventions.Zhao Y, Dimitrov DT, Liu H, Kuang Y.Zhao Y, et al.Bull Math Biol. 2013 Apr;75(4):649-75. doi: 10.1007/s11538-013-9824-7. Epub 2013 Feb 23.Bull Math Biol. 2013.PMID:23435680Free PMC article.
- Clinical predictors cannot replace biological predictors in HIV-2 infection in a community setting in West Africa.Gourlay AJ, van Tienen C, Dave SS, Vincent T, Rowland-Jones SL, Glynn JR, Whittle HC, van der Loeff MF.Gourlay AJ, et al.Int J Infect Dis. 2012 May;16(5):e337-43. doi: 10.1016/j.ijid.2012.01.001. Epub 2012 Mar 2.Int J Infect Dis. 2012.PMID:22387142Free PMC article.
- Modelling the spread of HIV immune escape mutants in a vaccinated population.Fryer HR, McLean AR.Fryer HR, et al.PLoS Comput Biol. 2011 Dec;7(12):e1002289. doi: 10.1371/journal.pcbi.1002289. Epub 2011 Dec 1.PLoS Comput Biol. 2011.PMID:22144883Free PMC article.
- Progression to WHO criteria for antiretroviral therapy in a 7-year cohort of adult HIV-1 seroconverters in Abidjan, Côte d'Ivoire.Minga A, Danel C, Abo Y, Dohoun L, Bonard D, Coulibaly A, Duvignac J, Dabis F, Salamon R, Anglaret X; ANRS 1220 Study Group.Minga A, et al.Bull World Health Organ. 2007 Feb;85(2):116-23. doi: 10.2471/blt.06.032292.Bull World Health Organ. 2007.PMID:17308732Free PMC article.
- Endpoints and regulatory issues in HIV vaccine clinical trials: lessons from a workshop.Follmann D, Duerr A, Tabet S, Gilbert P, Moodie Z, Fast P, Cardinali M, Self S.Follmann D, et al.J Acquir Immune Defic Syndr. 2007 Jan 1;44(1):49-60. doi: 10.1097/01.qai.0000247227.22504.ce.J Acquir Immune Defic Syndr. 2007.PMID:17075387Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials